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Purpose: To investigate the relationship between metabolic 
syndrome as defined by using the modified NCEP/ATP III criteria 
[modified the National Cholesterol Education Program (NCEP)/Adult 
Treatment Panel III (ATP III) criteria] and cigarette smoking in Thai 
subjects.  
Methods: This study was carried out among 254 smokers and 144 
nonsmokers from suburban and urban residential areas in Bangkok, 
Thailand. All anthropometric variables, blood pressures, resting heart 
rate and biochemical parameters in each subject were measured.  
Results: The anthropometric variables, biochemical parameters, 
blood pressures and resting heart rate were not significantly different 
between smokers and nonsmokers, except for white blood cell count 
(WBC). Cigarette smoking was associated with increased risk for 
metabolic syndrome (OR =1.97; 95% CI=1.11-3.42) and the 
percentages of metabolic syndrome in smoker and nonsmoker Thais 
were 22.8% and 13.2%, respectively. Moreover, the number of 
cigarette smoking per day showed significant association with 
metabolic syndrome (p=0.047). Logistic regression analysis revealed 
that cigarette pack-years, resting heart rate, body mass index (BMI) 
and total cholesterol were significantly increased risk factors for 
metabolic syndrome.   
Conclusion: The current findings suggest that cigarette smoking is 
associated with the increased risk of metabolic syndrome by using the 
modified NCEP/ATP III criteria in Thais. 
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Nowadays, the prevalence of metabolic syndrome 
is increasing in the world and reports from many 
countries had similar prevalence rates ranging 
between 10-20% [1-3]. The prevalence in 
Nongkhai province, Thailand is about 17% [4]. 
Metabolic syndrome is a cluster of risk factors 
predictive of future cardiovascular diseases and 
type 2 diabetes mellitus [5-6]. Many factors, 
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including physical inactivity, obesity, and an 
unhealthy diet, appeared to promote the 
development of the disease [7], but the 
mechanisms causing the onset are not fully 
understood.  
 
Smoking may be considered as an important 
modifiable risk factor for metabolic syndrome. 
Cigarette smoking is an important health problem 
in Thailand, and the proportion of smokers is 
approximately 21.2 percent [8]. It is considered to 
increase morbidity and the mortality risk of many 
chronic diseases such as atherosclerosis, 
cardiovascular diseases, type 2 diabetes, emphy-
sema, and various types of malignancies [9-10]. 
Chemical components of cigarette smoke, other 
than nicotine, contribute to cardiovascular injury 
by causing production of carboxyhaemoglobin, 
increasing platelet aggregation, adversely 
affecting the lipid profile and producing oxidant 
injury [11,12]. Smokers have abnormalities in 
lipoprotein metabolism and endothelial function 
[13]. Several studies reported that smoking also 
induced insulin resistance and conducted to type 
2 diabetes [6,14]. However, the link between 
smoking and metabolic syndrome has not been 
properly elucidated. Although some earlier 
studies have not found the relationship between 
smoking and metabolic syndrome [15-17], none 
of these studies was done in Thai subjects. Thus, 
the objective of this study was to investigate the 
relationship between metabolic syndrome and 






Following approval by the Ethics Committee of 
Faculty of Tropical Medicine, Mahidol 
University, Bangkok, a convenient sample size of 
398 Thai volunteers (aged 21 to 62 years) were 
recruited from suburban and urban residential 
areas in Bangkok, Thailand. These excluded 
subjects with a history of diabetes mellitus, liver, 
kidney and cardiovascular diseases as confirmed 
by physical appropriate examinations and 
laboratory tests. Of these subjects, 254 were 
smokers, while the rest (144) were nonsmokers. 
Using an interview format, all the volunteers 
were interviewed to obtain information on their 
lifestyle pattern, and medical history. Smoking 
characteristics such as age at onset of smoking, 
the number of cigarettes smoked and duration of 
smoking (years) were recorded in details. 
Cigarette pack-years were computed as duration 
of smoking (years) multiplied by the number of 
smoked cigarettes and divided by 20.  
 
Overnight fasting venous blood (5 ml) was taken 
from each subject. Serum was used to assay 
biochemical variables e.g. total cholesterol, 
triglycerides, HDL-cholesterol, aspartate 
aminotransferase (AST), alanine aminotrans-
ferase (ALT) and alkaline phosphatase (ALP). 
NaF blood was used to assay glucose and EDTA 
blood was used to assay hematological variables 
e.g. hemoglobin, hematocrit, and white blood cell 
count (WBC).  
 
Anthropometric measurements, comprising 
weight, height, triceps skinfold thickness (TSF), 
waist circumference, and hip circumference for 
each subject were determined. For each subject, 
the waist and hip circumferences were measured 
and the waist and hip circumference ratio 
calculated. Body mass index (BMI) was 
determined and expressed as weight (kg) / height 
(m
2
). Resting heart rate and blood pressure (BP) 
were measured by a nurse after 5 to 10 minutes of 




For each subject, glucose, total cholesterol, 
triglycerides, HDL-cholesterol, AST, ALT and 
ALP were measured using enzymatic methods by 
DADE Dimension 
®
AR. Hemoglobin as well as 
hematocrit concentrations and WBC count were 
determined by Coulter Counter. 
 
Criteria for metabolic syndrome 
 
The metabolic syndrome was defined by using 
the modified NCEP/ATP III criteria [18]. The 
new cut-off on waist circumference in the Asia 
pacific region was used instead of original cut-off 
for waist circumference in ATP III criteria. The 
modified NCEP/ ATP III definition required at 
least three of the followings: (1) raised waist 
circumference: >90 cm in men and >80 cm in 
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women for Asians, (2) raised triglyceride level 
which is > 150 mg/dL, (3) reduced high-density 
lipoprotein (HDL)-cholesterol which is < 
40mg/dL in men and <50 mg/dL in women, (4) 
raised blood pressure: systolic blood pressure 
>130 mmHg or diastolic blood pressure > 85 
mmHg or current antihypertensive medication, 





Statistical calculations were performed using 
SPSS for Windows version 17.0 (SPSS, Chicago, 
IL). The median and 95% confidence interval 
(C.I.) were calculated. Difference between two 
groups was determined using the Mann-Whitney 
U-Wilcoxon Rank Sum W test. Relationship 
between metabolic syndrome and cigarette 
smoking was tested using Chi-square test and 
odds ratio (OR) determined as appropriate. To 
assess the association between metabolic 
syndrome as dependent variable and potential 
factors, logistic regression was applied. At 95% 
confidence interval, p values <0.05 were 
considered statistically significant. The goodness 
of fit of the logistic regression models was tested 




The median and 95% confidence intervals of the 
age, blood pressures, resting heart rate, 
biochemical and hematological measurements as 
well as anthropometric variables in smokers and 
nonsmokers are shown in Table 1. All 
anthropometric variables, biochemical 
parameters, blood pressures and resting heart rate 
among the smokers were not statistically 
significantly different from those of the 
nonsmokers. Significantly higher WBC counts 
were observed among the smokers when 
compared with the nonsmokers.  
 
The percentage of metabolic syndrome in this 
study is presented in Table 2. As defined by the 
modified NCEP / ATP III criteria, 77 (19.3%) of 
 
Table 1: Age, anthropometric variables, biochemical and hematological parameters of volunteers 
 
Smokers (n= 254) Nonsmokers (n=144) Parameters 
Median   95%C.I. Median  95%C.I. 
   p-value 
Age (years) 37 35-40 36 34-39 0.289 
BMI (kg/m2) 23.66 23.00-24.02 23.36 22.84-24.32 0.462 
Waist (cm) 83.00 80.80-85.00 83 80.79-85.00 0.467 
Hip (cm) 96 95-97 96 94-97 0.959 
Waist/Hip ratio 0.86 0.85-0.87 0.87 0.85-0.88 0.227 
TSF (mm) 12.00 10.50-13.00 12.05 10.59-13.40 0.946 
Systolic BP (mmHg) 120 120-122 120 116-123 0.781 
Diastolic BP (mmHg) 80 78-80 78 76-80 0.434 
Resting heart rate 
(beats/minute) 
73 72-75 72 69-73 0.061 
Glucose (mg/dL) 85 83-87 82 79-84 0.093 
Total cholesterol 
(mg/dL) 
204 197-210 203 198-210 0.902 
Triglycerides (mg/dL) 124 114-138 121 112-129 0.122 
HDL-C (mg/dL) 49 48-51 50 48-52 0.925 
AST (U/L) 30 29-33 29 27-32 0.348 
ALT (U/L) 30 28-33 31 28-33 0.397 
ALP (U/L) 74 70-76 69 66-72 0.076 
Hemoglobin (g/dL)  14.8 14.7-15.0 14.6 14.4-15.0 0.371 
Hematocrit % 44.6 44.1-45.1 44.3 44.0-44.9 0.413 
WBC (109/L) 7,100 6,800-7,500 5,900 5,700-6,300 0.000* 
            *p < 0.05  
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Table 2: Prevalence of metabolic syndrome in smokers 







syndrome   
n=321 
Smokers 58 (22.8) 196 (77.2) 
Nonsmokers 19 (13.2) 125 (86.8) 
 
the subjects had the metabolic syndrome. 
Smoking was found associated with increased 
risk for metabolic syndrome (OR=1.97; 95% 
C.I.=1.11-3.42, p=0.019) (Table 2). The 
prevalence of metabolic syndrome increased 
proportionally with increase in the number of 
cigarettes smoked per day (Table 3). BMI (OR 
=1.48, p<0.01), resting heart rate (OR =1.07, 
p=0.011), total cholesterol (OR =1.01, p=0.025) 
and cigarette pack-years (OR =1.08, p=0.009) 
had significant impact on the metabolic 
syndrome. 
 
Table 3: Prevalence of metabolic syndrome according 
to the number of cigarette smoking per day. 
 
Cigarettes per day 
Prevalence of  metabolic 
syndrome (n= 58) 
1-5 17.5% (n=7) 
6-10 19.8% (n=20) 
11-20 24.3% (n=18) 
>20 33.3% (n=13) 




In this study, we found a good relationship 
between cigarette smoking and metabolic 
syndrome in Thai subjects. This finding is 
consistent with results from previous 
epidemiologic studies [19-20]. In Japanese, 
smoking was positively related to metabolic 
syndrome (OR=1.4) and the prevalence of 
metabolic syndrome was 19% in male smokers 
who did not drink [19]. In Korean, the prevalence 
of metabolic syndrome in sustained smokers was 
14% [20]. Studies in Taiwan and in Korea 
showed a higher prevalence of metabolic 
syndrome in smokers than in never smokers and 
current smoking had a significant dose-dependent 
association with metabolic syndrome [21-22]. 
Although many pharmacological actions of 
cigarette smoking and nicotine have been 
demonstrated [23-24], the mechanism of how 
cigarette smoking increases the risk of the 
metabolic syndrome is still not clear. Insulin 
resistance is the key pathophysiology of 
metabolic syndrome [25]; previous study has 
shown that long-term cigarette smokers are 
insulin resistance [26]. A negative effect of 
cigarette smoking on insulin-mediated glucose 
uptake has been documented in studies [26-27]. 
Cigarette smoking elevates the circulating 
concentrations of insulin-antagonistic hormones 
[28] and chemical components of cigarette smoke 
may have direct toxic effects on the pancreas as 
well as on insulin receptor sensitivity [24]. Thus, 
cigarette smoking may contribute to the 
metabolic disturbances and may increase the risk 
of the metabolic syndrome. On the other hand, 
some studies had not found the relationship 
between smoking and the metabolic syndrome 
[29-31]. Gharipour et al reported that the 
percentage of nonsmokers with three components 
of metabolic syndrome was higher than in 
smokers [29] and in Iranian middle aged women, 
the odds ratio showed no significant association 
 
Table 4: Multivariate logistic regression analysis when metabolic syndrome was used as dependent variable and 













BMI 0.39 1.48 1.28-1.70 <0.001* 
Resting heart rate 0.07 1.07 1.01-1.12 0.011* 
Total cholesterol 0.01 1.01 1.00-1.02 0.025* 
WBC 0.00 1.00 1.00-1.00 0.727 
Cigarette pack-years 0.08 1.08 1.02-1.15 0.009* 
            *p<0.05 
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between metabolic syndrome and smoking [28]. 
Moreover, our findings support that cigarette 
smoking has adverse affect on health. 
Multivariate logistic regression in this study 
showed that BMI, resting heart rate, total 
cholesterol and cigarette pack-years had 
significant impact on the metabolic syndrome, 
which is consistent with previous findings [32-
33]. That elevated resting heart rate is associated 
with metabolic syndrome in both men and 
women has been reported by Rogowski et al [32]. 
BMI and total cholesterol were significantly 
higher in present metabolic syndrome group than 
non metabolic syndrome group [34]. Gnacnska et 
al also showed that increased BMI was the 
biggest factors stimulating manifestation of 
metabolic syndrome [33] and BMI was the 
positive associated factor to the diagnosis of 
metabolic syndrome in logistic regression model 




Our study found that cigarette smoking is 
associated with metabolic syndrome. Smokers 
had higher circulating WBC count than 
nonsmokers and the trend of resting heart rate 
increases in smokers. These observations may 
provide the data to promote antismoking 
campaign. Further investigation should clarify the 
mechanisms between cigarette smoking and the 




The authors wish to express their sincere thanks 
to all volunteers, all staff of Faculty of Medical 
Technology, Rangsit University and staff of the 
Department of Tropical Nutrition and Food 
Science, Faculty of Tropical Medicine, Mahidol 
University for their cooperation in this research. 
This work was supported by funds from Rangsit 
University and Mahidol University, Thailand. 
 
Conflict of Interest  
 
We declare that we have no conflict of interest 
associated with this work. 
 
Contribution of Authors 
 
We declare that this work was done by the 
authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by the authors. Kanjana 
Suriyaprom
 
collected specimens and carried out 
laboratory analysis as well as preparation of the 
manuscript and contributed to the design of the 
study. 
 
Pisit Namjuntra carried out laboratory 
analysis and was involved in preparation of the 
manuscript. Rungsunn Tungtrongchitr and 
Kittisak Thawnasom collected specimens and 
analyzed the data.  Yaowaluk Pimainog was  
involved in the preparation of manuscript. All 




1. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds 
RF, Whelton PK, He J, InterASIA Collaborative 
Group. Prevalence of the metabolic syndrome and 
overweight among adults in China. Lancet 2005; 
365: 1398-1405. 
2.   Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, 
So WY, Chan NN, Chan JC. High prevalence of 
metabolic syndrome in Hong Kong Chinese--
comparison of three diagnostic criteria. Diabet Res 
Clin Pract 2005; 69: 160-168. 
3.   Yoon YS, Oh SW, Baik HW, Park HS, Kim WY. 
Alcohol consumption and the metabolic syndrome 
in Korean adults: the 1998 Korean National Health 
and Lamthong Kaewtrakulpong. Metabolic 
Syndrome: Prevalence in Si Chiang Mai District, 
Nong Khai Province, Thailand. J Trop Med 
Parasitol 2008; 31: 41-47. 
4.   Nutrition Examination Survey. Am J Clin Nutr 2004; 
80: 217-224. 
5.   Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien 
GJ, Pio JR, Williams GR. Impact of the metabolic 
syndrome on mortality from coronary heart 
disease, cardiovascular disease, and all causes in 
United States adults. Circulation 2004; 110: 1245-
1250. 
6.   Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, 
Salonen JT, Lakka TA. Metabolic syndrome and 
development of diabetes mellitus: application and 
validation of recently suggested definitions of the 
metabolic syndrome in a prospective cohort study. 
Am J Epidemiol 2002; 156: 1070-1077. 
7.   Grundy SM, Hansen B, Smith Jr SC, Cleeman JI, Kahn 
RA. Clinical management of metabolic syndrome: 
report of the American Heart Association/National 
Heart, Lung, and Blood Institute/American 
Diabetes Association conference on scientific 
issues related to management, Circulation 2004; 
109: 551-556. 
Suriyaprom et al                            Smoking and Metabolic Syndrome in Thais 
 
Int J Health Res, December 2010; 3(4):   212 
8.   Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett 
WC. Prospective study of cigarette smoking, 
alcohol use, and the risk of diabetes in men. BMJ 
1995; 310: 555-559. 
9.   Diana JN. Tobacco smoking and nutrition. Ann N Y 
Acad Sci 1993; 686: 1-11. 
 
10. Suriyaprom K, Tungtrongchitr R. Cigarette: risk factors 
of cardiovascular diseases. J Tobacco Control 
2007; 1: 77-85. 
11. Suriyaprom K, Tungtrongchitr R, Namjuntra P. Free 
radicals and antioxidants in cigarette smokers.  J 
Med Tech Assoc Thailand 2006; 34: 1349-1360. 
12. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, 
Evans GW, McGovern P, Nieto FJ, Tell GS. 
Cigarette smoking and progression of 
atherosclerosis: The Atherosclerosis Risk in 
Communities (ARIC) Study. JAMA 1998; 
279:119-124. 
13. Kong C, Nimmo L, Elatrozy T, Anyaoku V, Hughes C, 
Robinson S, Richmond W, Elkeles RS. Smoking is 
associated with increased hepatic lipase activity, 
insulin resistance, dyslipidaemia and early 
atherosclerosis in type 2 diabetes. Atherosclerosis 
2001; 156: 373-378. 
14. Nakanishi N, Nakamura K, Matsuo Y, Suzuki K, Tatara 
K. Cigarette smoking and risk for impaired fasting 
glucose and type 2 diabetes in middle-aged 
Japanese men. Ann Intern Med 2000; 133: 183-
191. 
15. Gharipour M, Kelishadi R, Sarrafzadegan N, Baghaei A, 
Yazdani M, Anaraki J, Eshrati B, Tavassoli AA. 
The association of smoking with components of 
the metabolic syndrome in non-diabetic patients. 
Ann Acad Med Singapore 2008; 37: 919-923. 
16. Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan ST. 
Prevalence of metabolic syndrome among middle 
aged women in Babol, Iran. Southeast Asian J 
Trop Med Public Health 2009; 40: 612-628. 
17. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, 
Liu K. Coronary Artery Risk Development in 
Young Adults study: Risk factors for the metabolic 
syndrome: the Coronary Artery Risk Development 
in Young Adults (CARDIA) study, 1985-2001. 
Diabet Care 2004; 27: 2707-2715. 
18. Rahim MA, Azad Khan AK, Sayeed MA, Akhtar B, 
Nahar Q, Ali SMK, Hussain A. Metabolic 
syndrome in rural Bangladesh: Comparison of 
newly proposed IDF, modified ATP III and WHO 
criteria and their agreements. Clin Res Rev 2007; 
1: 251-257.   
19. Takeuchi T, Nakao M, Nomura K, Yano E. Association 
of metabolic syndrome with smoking and alcohol 
intake in Japanese men. Nicotine Tob Res 2009; 
11: 1093-1098.  
20. Kim BJ, Kim BS, Sung KC, Kang JH, Lee MH, Park JR. 
Association of smoking status, weight change, and 
incident metabolic syndrome in men: a 3-year 
follow-up study. Diabet Care 2009; 32: 1314-1316.  
21. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, 
Li CI, Lai MM, Lin CC. Association among 
cigarette smoking, metabolic syndrome, and its 
individual components: the metabolic syndrome 
study in Taiwan. Metabol 2008; 57: 544-548. 
22. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, 
Jeong EK, Yoo T, Korea National Health and 
Nutrition Examination Survey. Association 
between cigarette smoking and metabolic 
syndrome: the Korea National Health and 
Nutrition Examination Survey. Diabet Care 2005; 
28: 2064-2066. 
23. Benowitz NL. Pharmacologic aspects of cigarette 
smoking and nicotine addition. N Engl J Med 
1988; 319: 1318-30. 
24. Pasupathi P, Bakthavathsalam G, Rao YY, Farook J. 
Cigarette smoking—Effect of metabolic health 
risk: A review. Clin Res Rev 2009; 3: 120–127. 
25. Alberti KG, Zimmet PZ. Definition, diagnosis and 
classification of diabetes mellitus and its 
complications. Part 1: diagnosis and classification 
of diabetes mellitus provisional report of a WHO 
consultation. Diabet Med 1998; 15: 539-53. 
26. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, 
Reaven GM. Insulin resistance and cigarette 
smoking. Lancet 1992; 339: 1128-1130. 
27. Rönnemaa T, Rönnemaa EM, Puukka P, Pyörälä K, 
Laakso M. Smoking is independently associated 
with high plasma insulin levels in nondiabetic 
men. Diabet Care 1996; 19: 1229-1232. 
28. Kirschbaum C, Wust S, Strasburger CJ. ‘Normal’ 
cigarette smoking increases free cortisol in 
habitual smokers. Life Sci 1992; 50: 435-442. 
29. Gharipour M, Kelishadi R, Sarrafzadegan N, Baghaei A, 
Yazdani M, Anaraki J, Eshrati B, Tavassoli AA. 
The association of smoking with components of 
the metabolic syndrome in non-diabetic patients. 
Ann Acad Med Singapore 2008; 37: 919-923. 
30. Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan ST. 
Prevalence of metabolic syndrome among middle 
aged women in Babol, Iran. Southeast Asian J 
Trop Med Public Health 2009; 40: 612-628. 
31. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, 
Liu K. Coronary Artery Risk Development in 
Young Adults study. Risk factors for the metabolic 
syndrome: the Coronary Artery Risk Development 
in Young Adults (CARDIA) study, 1985-2001. 
Diabet Care 2004; 27: 2707-2715. 
32. Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, 
Ben-Bassat OK, Shapira I. Elevated resting heart 
rate is associated with the metabolic syndrome. 
Cardiovasc Diabetol 2009; 8: 55. 
33. Gnacińska M, Małgorzewicz S, Lysiak-Szydłowska W, 
Sworczak K. The serum profile of adipokines in 
overweight patients with metabolic syndrome. 
Endokrynol Pol 2010; 61: 36-41. 
34. Tonstad S, Svendsen M. Premature coronary heart 
disease, cigarette smoking, and the metabolic 
syndrome. Am J Cardiol 2005; 96: 1681-1685.  
35. Limpawattana P, Sawanyawisuth K, Busaracome P, 
Foocharoen C, Phitsanuwong C, Chumjan S, 
Chotmongkol R, Chaisuksant S. The best criteria 
to diagnose metabolic syndrome in hypertensive 
Thai patients. J Med Assoc Thai. 2008; 91(4): 485-
490. 
